Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Pharmacy Creations is recalling 52 vials of Magnesium Chloride 20% Injection because contract testing indicated the product may not be sterile.
Vann Healthcare Services is recalling 410 epinephrine syringes because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to assure sterility.
New Life Nutritional Center is recalling Super Fat Burner and other products because they contain undeclared and unapproved drugs.
Hospira is recalling 63,378 units of Heparin Sodium injection because human hair was found sealed inside the container's administration port.
New Life Nutritional Center is recalling Esmeralda, Super Fat Burner, and Maxi Gold Weight Loss Pill due to undeclared and unapproved drugs.
Vann Healthcare Pharmacy is recalling Tri-mix #4 vials because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility.
Vann Healthcare Services is recalling Lidocaine 4% syringes because an FDA inspection found deficiencies in the facility's ability to assure sterility.
New Life Nutritional Center is recalling specific weight loss and dietary supplement products because they contain undeclared and unapproved drugs.
Chaotic Labz is recalling MAYHEM capsules because FDA analysis found undeclared dexamethasone and cyproheptadine, making the product an unapproved drug.
Neolpharma, Inc. is voluntarily recalling 12,310 bottles of 0.25 mg alprazolam tablets nationwide because the medication was found to be subpotent.
LNK International recalled specific lots of Walgreens Aspirin Free Tension Headache Caplets because they contain sucralose, an ingredient not listed on the label.
Zydus Pharmaceuticals USA is recalling 19,536 units of Benzonatate capsules because some are wet or leaking. The recall is nationwide.
Vann Healthcare Services is recalling Hydroxyprogesterone Caproate vials because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility.
K C Pharmaceuticals is recalling Sunmark Eye Drops because the active ingredient was stored in a non-GMP compliant warehouse in Italy.
KC Pharmaceuticals is recalling 302,976 bottles of Eye Drops A.C. because the active ingredient was stored in a non-GMP compliant warehouse in Italy.
K C Pharmaceuticals is recalling specific lots of Eye Drops Industrial Strength because the active ingredient was stored in a non-GMP compliant warehouse in Italy.
KC Pharmaceuticals is recalling Sunmark Eye Drops Advanced Moisturizer/Lubricant because the active ingredient was stored in a non-GMP compliant warehouse in Italy.
J. Strickland and Co is recalling Sulfur8 Medicated Anti-Dandruff Conditioner because the product pH failed to meet specifications.
Hospira Inc. is recalling 3,306 vials of Dacarbazine Injection, USP, 200mg, because the reconstituted solution may appear pink instead of the expected colorless to pale yellow.
Hospira Inc. is recalling Meropenem I.V. 1 g vials because thin glass walls may crack, leading to contamination and sterility issues.
Baxter Healthcare is recalling 7,220 bags of Clinimix E IV solution because leaks were observed, raising concerns about sterility.
Zydus Pharmaceuticals is recalling 58,920 bottles of Benzonatate Capsules, 200 mg, because some capsules are wet or leaking.
American Health Packaging is recalling specific lots of Mercaptopurine Tablets, 50 mg, because they failed USP dissolution test requirements.
Eisai Inc. is recalling 121,680 bottles of Belviq (Lorcaserin HCl) 10 mg tablets because some bottles may lack labels or have illegible lot and expiry dates.
Wockhardt USA is recalling specific lots of Metoprolol Succinate Extended-Release Tablets because they failed long-term stability testing for dissolution specifications.